AU2002356824A1 - Novel methods for introducing molecules into cells and vectors and compositions for use in such methods - Google Patents

Novel methods for introducing molecules into cells and vectors and compositions for use in such methods

Info

Publication number
AU2002356824A1
AU2002356824A1 AU2002356824A AU2002356824A AU2002356824A1 AU 2002356824 A1 AU2002356824 A1 AU 2002356824A1 AU 2002356824 A AU2002356824 A AU 2002356824A AU 2002356824 A AU2002356824 A AU 2002356824A AU 2002356824 A1 AU2002356824 A1 AU 2002356824A1
Authority
AU
Australia
Prior art keywords
methods
vectors
compositions
cells
introducing molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002356824A
Inventor
Dennis R. Burton
Peter Ghazal
Klaus M. Hahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU2002356824A1 publication Critical patent/AU2002356824A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU2002356824A 2001-10-19 2002-10-18 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods Abandoned AU2002356824A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3931801A 2001-10-19 2001-10-19
US10/039,318 2001-10-19
PCT/US2002/033305 WO2003035892A2 (en) 2001-10-19 2002-10-18 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods

Publications (1)

Publication Number Publication Date
AU2002356824A1 true AU2002356824A1 (en) 2003-05-06

Family

ID=21904830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002356824A Abandoned AU2002356824A1 (en) 2001-10-19 2002-10-18 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods

Country Status (3)

Country Link
EP (1) EP1436315A2 (en)
AU (1) AU2002356824A1 (en)
WO (1) WO2003035892A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126885A1 (en) 2002-11-05 2004-07-01 Cines Douglas B. Delivery vehicle for recombinant proteins
JP4759707B2 (en) * 2004-05-28 2011-08-31 ハミダ・フォー・ライフ・ベスローテン・フェンノートシャップ Nanoscale electronic detection system and manufacturing method thereof
BRPI0617688A2 (en) 2005-10-21 2011-06-07 Hoffmann La Roche method for recombinant expression of a polypeptide
EP2218458A1 (en) * 2009-02-13 2010-08-18 Fondazione Telethon Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
JP5764921B2 (en) * 2009-12-24 2015-08-19 Jnc株式会社 Fusion protein with luminescent activity
SG10202110492YA (en) 2017-06-22 2021-11-29 Catalyst Biosciences Inc Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use
US11613744B2 (en) 2018-12-28 2023-03-28 Vertex Pharmaceuticals Incorporated Modified urokinase-type plasminogen activator polypeptides and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652122A (en) * 1989-12-21 1997-07-29 Frankel; Alan Nucleic acids encoding and methods of making tat-derived transport polypeptides
ES2123062T3 (en) * 1992-08-21 1999-01-01 Biogen Inc TRANSPORTATION POLYPEPTIDES DERIVED FROM TAT PROTEIN.

Also Published As

Publication number Publication date
WO2003035892A2 (en) 2003-05-01
EP1436315A2 (en) 2004-07-14
WO2003035892A3 (en) 2003-07-17
WO2003035892A9 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
AU1803601A (en) Methods and compositions for the introduction of molecules into cells
AU2002340415A1 (en) Compositions containing enzymes stabilized with certain osmo-protectants and methods for using such compositions in personal care
AU2002248297A1 (en) Aav2 vectors and methods
AU2002321903A1 (en) Molecular interactions in cells
AU2003211005A1 (en) Compositions comprising reproductive cell media and methods for using such compositions
AU2002313281A1 (en) Fuel cell and electric apparatus
AU2002311756A1 (en) Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same
AU2002327380A1 (en) Cells and methods for propagating adenoviral vectors
AU2002256347A1 (en) Compositions and methods for the identification of protein interactions in vertebrate cells
AU2002356824A1 (en) Novel methods for introducing molecules into cells and vectors and compositions for use in such methods
AU3274401A (en) Compositions and methods for efficient aav vector production
AU2002338616A1 (en) Vector processor architecture and methods performed therein
AU2001240025A1 (en) Cell cycle proteins associated with rad9, compositions and methods of use
AU2002306645A1 (en) Compositions and methods for increasing amino acid absorption in mammals
AU2002332507A1 (en) Levothyroxine compositions and methods
AU2002305700A1 (en) Composition and method for treating cells
AU7636900A (en) Novel cells and molecules involved in immune regulation
AU2002238794A1 (en) Methods and compositions involved in groucho-mediated differentiation
AU2001242019A1 (en) Compositions and methods for use thereof in modifying the genomes of microorganisms
AU2002311749A1 (en) Narc10 and narc16, programmed cell death-associated molecules and uses thereof
AU2003252164A1 (en) Insulin-producing cell compositions and related methods
AU2002336522A1 (en) Compositions and methods for t cell priming and immunotherapy
AU2002336630A1 (en) Methods and compositions for use in agriculture
AU2002231923A1 (en) Vector for introducing molecules in eukaryotic cells and molecules vectorized by same
IL157005A0 (en) Vector for introducing molecules in eukaryotic cells and molecules vectorized by same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase